Silo Pharma (SILO) Invested Capital (2021 - 2023)

Silo Pharma has reported Invested Capital for 3 years, with the latest figure at $660279.0 in Q1 2023.

• Quarterly Invested Capital rose 918.34% year-over-year to $660279.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $660279.0 (up 35.77% YoY) and the FY2022 annual result came in at $364216.0, down 12.85% from the prior year.
• Invested Capital climbed to $660279.0 in Q1 2023 per SILO's latest filing, from $364216.0 in the prior quarter.
• Over five years, Invested Capital peaked at $660279.0 in Q1 2023 and troughed at $2366.0 in Q1 2021.
• A 3-year average of $190123.1 and a median of $72102.0 in 2021 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 2640.45% in 2022, down 77.19% in 2022.
• Over 3 years, Invested Capital stood at $417937.0 in 2021, then slipped by 12.85% to $364216.0 in 2022, then soared by 81.29% to $660279.0 in 2023.
• According to Business Quant data, Invested Capital over the past three periods registered $660279.0, $364216.0, and $16447.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.